From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-22
DOI
10.3389/fonc.2019.01307
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A reinforcing HNF4–SMAD4 feed-forward module stabilizes enterocyte identity
- (2019) Lei Chen et al. NATURE GENETICS
- Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma
- (2019) Jing Zhang et al. Molecular Cancer
- CDK7 inhibition suppresses Castration-Resistant Prostate Cancer through MED1 inactivation
- (2019) Reyaz Ur Rasool et al. Cancer Discovery
- Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
- (2019) Zhao Zhang et al. Nature Communications
- HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis
- (2018) Wanju Jiao et al. ONCOGENE
- Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes
- (2018) Kevin C. Osum et al. Scientific Reports
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Checkpoint inhibitor colitis
- (2018) Spyros I. Siakavellas et al. CURRENT OPINION IN GASTROENTEROLOGY
- Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA-eGREB1
- (2018) Mengting Ding et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation
- (2018) Homa Rahnamoun et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
- (2018) Yuan Jiang et al. Nature Communications
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1
- (2018) Lihua Shi et al. MOLECULAR IMMUNOLOGY
- Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors
- (2017) D. Makarious et al. EUROPEAN JOURNAL OF CANCER
- Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants
- (2017) T.M. Aune et al. JOURNAL OF AUTOIMMUNITY
- Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells
- (2017) Charles F. Spurlock et al. JOURNAL OF IMMUNOLOGY
- MYC expression correlates with PD-L1 expression in non-small cell lung cancer
- (2017) Eun Young Kim et al. LUNG CANCER
- eRNA binding produces tailored CBP activity profiles to regulate gene expression
- (2017) Daniel A. Bose et al. RNA Biology
- Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
- (2017) Wencheng Zhang et al. OncoTargets and Therapy
- PD1 signal transduction pathways in T cells
- (2017) Hugo Arasanz et al. Oncotarget
- The Super-Enhancer-Derived alncRNA-EC7/Bloodlinc Potentiates Red Blood Cell Development in trans
- (2017) Juan R. Alvarez-Dominguez et al. Cell Reports
- BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
- (2017) Simon J. Hogg et al. Cell Reports
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
- (2017) Michael Dougan Frontiers in Immunology
- Functional annotation of structural ncRNAs within enhancer RNAs in the human genome: implications for human disease
- (2017) Chao Ren et al. Scientific Reports
- Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
- (2016) Curtis A. Clark et al. CANCER RESEARCH
- BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
- (2016) Yuhki Yokoyama et al. CANCER RESEARCH
- PD-1/PD-L and autoimmunity: A growing relationship
- (2016) Mohammad Reza Zamani et al. CELLULAR IMMUNOLOGY
- Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
- (2016) Toni K. Choueiri et al. CLINICAL CANCER RESEARCH
- Abatacept for the treatment of systemic lupus erythematosus
- (2016) Victor R. Pimentel-Quiroz et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The transcription factor BACH2 promotes tumor immunosuppression
- (2016) Rahul Roychoudhuri et al. JOURNAL OF CLINICAL INVESTIGATION
- Revisiting lncRNAs: How Do You Know Yours Is Not an eRNA?
- (2016) Joaquín M. Espinosa MOLECULAR CELL
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits
- (2016) Suhn Kyong Rhie et al. Epigenetics & Chromatin
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes
- (2016) Steven Blinka et al. Cell Reports
- T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex
- (2016) Arnulf Hertweck et al. Cell Reports
- Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium
- (2016) Eileen S. Kim et al. Journal of Immunology Research
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
- (2016) Noha Abdel-Wahab et al. PLoS One
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer
- (2015) K. Ota et al. CLINICAL CANCER RESEARCH
- CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis
- (2015) Samir Ounzain et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Super-enhancers delineate disease-associated regulatory nodes in T cells
- (2015) Golnaz Vahedi et al. NATURE
- RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene
- (2015) Lilach Pnueli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs
- (2015) Nasun Hah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcription factor trapping by RNA in gene regulatory elements
- (2015) A. A. Sigova et al. SCIENCE
- Regulatory T cell identity: formation and maintenance
- (2015) Xudong Li et al. TRENDS IN IMMUNOLOGY
- The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
- (2015) Yanna Tang et al. Oncotarget
- Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression
- (2015) Janneke G.C. Peeters et al. Cell Reports
- Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer
- (2014) K. Azuma et al. ANNALS OF ONCOLOGY
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
- (2014) Edmond Chipumuro et al. CELL
- Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus
- (2014) Jian-Feng Xiang et al. CELL RESEARCH
- CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
- (2014) L. Robert et al. CLINICAL CANCER RESEARCH
- The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity
- (2014) Suzanne Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Enhancer RNA Facilitates NELF Release from Immediate Early Genes
- (2014) Katie Schaukowitch et al. MOLECULAR CELL
- Genetic and epigenetic fine mapping of causal autoimmune disease variants
- (2014) Kyle Kai-How Farh et al. NATURE
- BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones
- (2014) Tomohiko Kanno et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Non-coding RNA derived from the region adjacent to the human HO-1 E2 enhancer selectively regulates HO-1 gene induction by modulating Pol II binding
- (2014) Atsushi Maruyama et al. NUCLEIC ACIDS RESEARCH
- Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation
- (2014) C.-L. Hsieh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
- (2014) H. S. Kuehn et al. SCIENCE
- Enhancer RNAs and regulated transcriptional programs
- (2014) Michael T.Y. Lam et al. TRENDS IN BIOCHEMICAL SCIENCES
- Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes
- (2014) Nicholas E. Ilott et al. Nature Communications
- Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes
- (2014) Raffaella Di Micco et al. Cell Reports
- Brief Report: Identification ofBACH2andRAD51Bas Rheumatoid Arthritis Susceptibility Loci in a Meta-Analysis of Genome-Wide Data
- (2013) Kate McAllister et al. ARTHRITIS AND RHEUMATISM
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- Do inhibitory immune receptors play a role in the etiology of autoimmune disease?
- (2013) Marloes J.M. Olde Nordkamp et al. CLINICAL IMMUNOLOGY
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
- (2013) Joel Crespo et al. CURRENT OPINION IN IMMUNOLOGY
- eRNAs Promote Transcription by Establishing Chromatin Accessibility at Defined Genomic Loci
- (2013) Kambiz Mousavi et al. MOLECULAR CELL
- Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation
- (2013) Wenbo Li et al. NATURE
- Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription
- (2013) Michael T. Y. Lam et al. NATURE
- Activating RNAs associate with Mediator to enhance chromatin architecture and transcription
- (2013) Fan Lai et al. NATURE
- BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia
- (2013) D Da Costa et al. Blood Cancer Journal
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- Controlling Long-Range Genomic Interactions at a Native Locus by Targeted Tethering of a Looping Factor
- (2012) Wulan Deng et al. CELL
- eRNAs Are Required for p53-Dependent Enhancer Activity and Gene Transcription
- (2012) Carlos A. Melo et al. MOLECULAR CELL
- The long-range interaction landscape of gene promoters
- (2012) Amartya Sanyal et al. NATURE
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Large-scale discovery of enhancers from human heart tissue
- (2011) Dalit May et al. NATURE GENETICS
- Widespread transcription at neuronal activity-regulated enhancers
- (2010) Tae-Kyung Kim et al. NATURE
- A unique chromatin signature uncovers early developmental enhancers in humans
- (2010) Alvaro Rada-Iglesias et al. NATURE
- Mediator and cohesin connect gene expression and chromatin architecture
- (2010) Michael H. Kagey et al. NATURE
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
- (2010) Andre Franke et al. NATURE GENETICS
- 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
- (2010) N. Ahmadiyeh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- (2010) M. P. Creyghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus
- (2009) Elizabeth C. Jury et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
- (2009) Mark M Pomerantz et al. NATURE GENETICS
- N-Myc Regulates a Widespread Euchromatic Program in the Human Genome Partially Independent of Its Role as a Classical Transcription Factor
- (2008) R. Cotterman et al. CANCER RESEARCH
- Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci
- (2008) Jason D Cooper et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started